department of medicine

fox chase temple bone marrow transplant program

Clinical Services

The Fox Chase-Temple Bone Marrow Transplant Program offers state-of-the-art clinical trials, including one-of-a-kind studies conducted only at the Fox Chase-Temple facility. Donor transplants may use either matched related or matched unrelated donors.

Indications for Autologous Transplants

• Acute myelogenous leukemia, in complete remission
• Acute lymphoblastic leukemia, in complete remission
• Relapsed or high-risk Hodgkin's disease
• Relapsed or high-risk, low, intermediate or high-grade non-Hodgkin's lymphoma
• Stage II or III multiple myeloma
• Relapsed germ cell/testicular tumors
• Chronic lymphocytic leukemia Rai Stage II-III
• Primary amyloidosis

Indications for Allogeneic Transplants

Allogeneic transplants or syngeneic transplants are available for patients with HLA identical donors or identical twin donors for the following diseases:

• Severe aplastic anemia or paroxysmal nocturnal hemoglobinuria
• Chronic myelogenous leukemia in chronic or accelerated phase
• Preleukemic and/or myelodysplastic syndromes
• Acute myelogenous leukemia in complete remission or early relapse
• Acute lymphoblastic leukemia in complete remission or early relapse
• Relapsed Hodgkin's and non-Hodgkin's lymphomas
• Relapsed multiple myeloma
• Selected patients with metastatic clear cell renal cancer will be considered for mini-transplant protocols after they have completed at least one cycle of immunotherapy
• Chronic lymphatic leukemia Rai Stage II-III
  

Return to top

Contact Information:

Fox Chase-Temple BMT Program

Friends Hall Physicians Building

7604 Central Avenue, Lower Level

Phila., PA 19111-2442

Kenneth F. Mangan, MD, FACP, Director

Appointments:

215-214-4191 or

215-214-4199

Transplant Coordinator:

Chris Miller

MillerCH@tuhs.temple.edu